Offer - Urjas Oil for just ₹ 1
Fycompa 4 Mg Tablet (28) is a commercial drug that is prescribed in the form of Tablet. Seizures are some of its major therapeutic uses.
The optimal dosage of Fycompa 4 Mg Tablet (28) is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
The side effects typically associated with Fycompa 4 Mg Tablet (28) include Dizziness, Vertigo, Blurred vision. Normally, these side effects of Fycompa 4 Mg Tablet (28) are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Fycompa 4 Mg Tablet (28) is Severe for pregnant women and Moderate for women who are breastfeeding. Further, the section on Fycompa 4 Mg Tablet (28) related warnings talks about Fycompa 4 Mg Tablet (28)'s effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Liver Failure, Liver Disease must refrain from the use of Fycompa 4 Mg Tablet (28) since this can cause severe adverse effects. The section on Fycompa 4 Mg Tablet (28) contraindications lists all such conditions.
Drug reaction of Fycompa 4 Mg Tablet (28) with other medicines has been reported. See below for a complete list.
You should also be aware that Fycompa 4 Mg Tablet (28) is not safe while driving, and is not addiction.
Fycompa 4 Mg Tablet (28) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Is the use of Fycompa 4 Mg Tablet (28) safe for pregnant women?
Fycompa shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Fycompa 4 Mg Tablet (28) safe during breastfeeding?
Breastfeeding women may feel side effects of Fycompa. If you see any side effects, stop taking Fycompa immediately and talk to your doctor. Take Fycompa again, only after your doctor's advice.
What is the effect of Fycompa 4 Mg Tablet (28) on the Kidneys?
Fycompa may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Fycompa 4 Mg Tablet (28) on the Liver?
There may be severe side effects of Fycompa on your liver. Do not take it unless a doctor says so.
What is the effect of Fycompa 4 Mg Tablet (28) on the Heart?
Fycompa is not harmful for the heart.
If you are suffering from any of the following diseases, you should not take Fycompa 4 Mg Tablet (28) unless your doctor advises you to do so -
Is this Fycompa 4 Mg Tablet (28) habit forming or addictive?
You may get addicted to Fycompa 4 Mg Tablet (28). Therefore, before taking it, consult your doctor.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Fycompa 4 Mg Tablet (28). So it is best to avoid driving.
Is it safe?
Fycompa 4 Mg Tablet (28) is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Yes, in many cases, taking Fycompa 4 Mg Tablet (28) can help with mental disorders.
Interaction between Food and Fycompa 4 Mg Tablet (28)
You can take Fycompa 4 Mg Tablet (28) with food.
Interaction between Alcohol and Fycompa 4 Mg Tablet (28)
Consult your doctor before consuming alcohol while taking Fycompa 4 Mg Tablet (28) as it can have severe side effects.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Fycompa® (perampanel)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1010-1012
